Revolutions Medical finalises manufacturing pact with MIG
MIG, pursuant to the manufacturing agreement with Revolutions Medical, has guaranteed the production and delivery of a minimum of five million 3cc safety syringes per month for a
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.